Late-stage presentation with decompensated cirrhosis is alarmingly common but successful etiologic therapy allows for favorable clinical outcomes
Fig 5
Kaplan-Meier estimates of two-year survival in patients with liver cirrhosis due to alcoholic liver disease and viral hepatitis.
After a follow-up of twelve months, the overall survival in the viral hepatitis group was significantly better (95.1% vs. 75.8%, log rank p < 0.001). After 24 months, 90.2% of patients in the viral hepatitis cohort were still alive compared to 71.1% in the ALD cohort (log rank p < 0.001).